SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 19.00
-0.70 (-3.55%)
Mar 2, 2026, 5:24 PM CET
SynAct Pharma AB Employees
SynAct Pharma AB had 8 employees as of December 31, 2025. The number of employees increased by 2 or 33.33% compared to the previous year.
Employees
8
Change (1Y)
2
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-13.85M SEK
Market Cap
1.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 2 | 33.33% |
| Dec 31, 2024 | 6 | 1 | 20.00% |
| Dec 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 2 | 66.67% |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 124 |
| Oncopeptides AB | 75 |
| Diamyd Medical AB | 41 |
| Egetis Therapeutics AB | 40 |
| Genovis AB (publ.) | 36 |
| Saniona AB | 31 |
| Xspray Pharma AB | 26 |
| Cantargia AB | 22 |